MX165338B - Entrega transdermica electrolitica de polipeptidos - Google Patents

Entrega transdermica electrolitica de polipeptidos

Info

Publication number
MX165338B
MX165338B MX010367A MX1036788A MX165338B MX 165338 B MX165338 B MX 165338B MX 010367 A MX010367 A MX 010367A MX 1036788 A MX1036788 A MX 1036788A MX 165338 B MX165338 B MX 165338B
Authority
MX
Mexico
Prior art keywords
polypeptide
aqueous
patient
suspension
transdermic
Prior art date
Application number
MX010367A
Other languages
English (en)
Inventor
Dan Sibalis
Sanford Rosen
Original Assignee
Drud Delivery Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drud Delivery Systems Inc filed Critical Drud Delivery Systems Inc
Publication of MX165338B publication Critical patent/MX165338B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un parche transdérmico para entregar por lo menos una droga o medicamento directamente a la corriente sanguínea del paciente que comprende en combinación a) por lo menos un polipéptido que tiene desde aproximadamente tres hasta aproximadamente 20 unidades de péptido y b) medios electrolíticos para el transporte transdérmico del polipéptido caracterizados por una densidad de corriente desde aproximadamente 0.5 microamperios/cm cuadrado hasta aproximadamente 1 miliamperio/cm cuadrado mediante lo cual la piel del paciente ni se irrita ni se forma eritema.
MX010367A 1987-02-10 1988-02-10 Entrega transdermica electrolitica de polipeptidos MX165338B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/012,889 US4878892A (en) 1987-02-10 1987-02-10 Electrolytic transdermal delivery of polypeptides

Publications (1)

Publication Number Publication Date
MX165338B true MX165338B (es) 1992-11-05

Family

ID=21757240

Family Applications (1)

Application Number Title Priority Date Filing Date
MX010367A MX165338B (es) 1987-02-10 1988-02-10 Entrega transdermica electrolitica de polipeptidos

Country Status (9)

Country Link
US (1) US4878892A (es)
EP (1) EP0278474B1 (es)
JP (1) JPH0647016B2 (es)
KR (1) KR970004037B1 (es)
AT (1) ATE135928T1 (es)
AU (1) AU608278B2 (es)
CA (1) CA1317879C (es)
DE (1) DE3855143T2 (es)
MX (1) MX165338B (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US5032109A (en) * 1987-02-10 1991-07-16 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5362307A (en) * 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
KR970011449B1 (ko) * 1988-01-29 1997-07-11 더 리전트 오브 디 유니버시티 오브 캘리포니아 이온전기 영동형 비침입 검체 채취 또는 이송 장치 및 방법
US5496266A (en) * 1990-04-30 1996-03-05 Alza Corporation Device and method of iontophoretic drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5374241A (en) * 1989-07-21 1994-12-20 Iomed, Inc. Electrodes for iontophoresis
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5167616A (en) * 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
US5087241A (en) * 1990-07-24 1992-02-11 Empi, Inc. Iontophoresis electrode with reservoir and injection site
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
US5464387A (en) * 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5356632A (en) * 1991-09-12 1994-10-18 S.I. Scientific Innovations Ltd. Transdermal drug delivery device
US5215520A (en) * 1991-09-17 1993-06-01 Centre Internationale De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Method for delivering an active substance topically or percutaneously
CA2087087C (en) * 1992-01-22 2000-07-18 Burton H. Sage, Jr. Molecules for iontophoretic delivery
US5443441A (en) * 1993-03-05 1995-08-22 De Claviere; Anne Marie Apparatus and method for transdermal delivery of cosmetic compositions
US5503632A (en) * 1994-04-08 1996-04-02 Alza Corporation Electrotransport device having improved cathodic electrode assembly
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
US6425892B2 (en) * 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
ATE263597T1 (de) * 1995-06-05 2004-04-15 Alza Corp Vorrichtung zur transdermalen iontophoretischen verabreichung von fentanyl und sufentanil
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
IE960375A1 (en) * 1995-06-05 1996-12-11 Alza Corp Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
US7572252B1 (en) * 1995-06-07 2009-08-11 Alza Corporation Electrotransport agent delivery method and apparatus
US5983130A (en) 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US5779661A (en) * 1995-12-11 1998-07-14 Physion, S.R.L. Method of treating dysfunctional bladder syndromes by electromotive drug administration
US6718201B1 (en) * 1996-06-07 2004-04-06 Alza Corporation Electrotransport agent delivery method and apparatus
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
CA2309955A1 (en) * 1997-11-12 1999-05-20 Alza Corporation Method for decreasing self-association of polypeptides
KR100247558B1 (ko) 1997-11-24 2000-05-01 김충섭 사이클로덱스트린을 이용한 이온토포레시스 개선방법
US6163720A (en) * 1997-12-18 2000-12-19 Alza Corporation Layered rate controlling membranes for use in an electrotransport device
US6374136B1 (en) 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US6275728B1 (en) 1998-12-22 2001-08-14 Alza Corporation Thin polymer film drug reservoirs
WO2002015801A1 (en) * 2000-08-24 2002-02-28 Encapsulation Systems, Inc. Substance delivery system
BR0114909A (pt) 2000-10-26 2004-02-03 Alza Corp Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
US20110005507A9 (en) 2001-01-23 2011-01-13 Rick Bagwell Real-time control of exhaust flow
US6908448B2 (en) * 2001-08-24 2005-06-21 Dermisonics, Inc. Substance delivery device
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE10228680A1 (de) * 2002-06-27 2004-01-22 Holden Development Limited, Tortola Grundlage für transdermale Formulierungen (PTF)
EP1599141A2 (en) * 2003-02-19 2005-11-30 Second Stage Ventures, Inc. Ultrasonically enhanced saline treatment for burn damaged skin
JP2006518640A (ja) * 2003-02-19 2006-08-17 セカンド ステージ ベンチャーズ インコーポレイテッド 経皮的薬物送達方法及び装置
CA2573955C (en) 2004-07-23 2013-12-17 Halton Company Improvements for control of exhaust systems
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
KR101522747B1 (ko) * 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
CA2724653A1 (en) 2008-05-21 2009-11-26 Ferring International Center S.A. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US7883487B2 (en) 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
PT2442821T (pt) 2009-06-18 2017-09-29 Allergan Inc Administração segura de desmopressina
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US9731121B2 (en) 2011-03-31 2017-08-15 Incline Therapeutics, Inc. Switch validation circuit and method
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
US8781571B2 (en) 2011-03-31 2014-07-15 Incline Therapeutics, Inc. Switch validation circuit and method
US9928115B2 (en) 2015-09-03 2018-03-27 Apple Inc. Hardware migration between dissimilar cores

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3163166A (en) * 1961-04-28 1964-12-29 Colgate Palmolive Co Iontophoresis apparatus
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4218255A (en) * 1976-08-30 1980-08-19 University Of Dayton Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method
US4250878A (en) * 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4475916A (en) * 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
EP0092015A1 (fr) * 1982-04-16 1983-10-26 Roland Brodard Dispositif d'ionisation
US4639244A (en) * 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4710497A (en) * 1983-05-20 1987-12-01 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4702732A (en) * 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
US4713244A (en) * 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
US4752285B1 (en) * 1986-03-19 1995-08-22 Univ Utah Res Found Methods and apparatus for iontophoresis application of medicaments
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device

Also Published As

Publication number Publication date
DE3855143T2 (de) 1996-10-31
EP0278474B1 (en) 1996-03-27
KR970004037B1 (ko) 1997-03-24
DE3855143D1 (de) 1996-05-02
EP0278474A1 (en) 1988-08-17
US4878892A (en) 1989-11-07
JPS63200775A (ja) 1988-08-19
KR880009632A (ko) 1988-10-04
JPH0647016B2 (ja) 1994-06-22
AU1098488A (en) 1988-08-11
AU608278B2 (en) 1991-03-28
CA1317879C (en) 1993-05-18
ATE135928T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
MX165338B (es) Entrega transdermica electrolitica de polipeptidos
DE2963513D1 (en) Non-invasive chemical species delivery apparatus
ES2106735T3 (es) Tratamiento de desordenes mediante la aplicacion de factores de crecimiento de tipo de insulina y analogos.
EP0748636A3 (en) Interface for iontophoresis
DE69512083D1 (de) Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport
ATE114486T1 (de) Verfahren und vorrichtung zur iontophoretischen abgabe von medikamenten.
DE69031083T2 (de) Gerät zur iontophoretischen verabreichung von medikamenten
ES2017187A6 (es) Electrodo de iontoforesis.
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
ATE255450T1 (de) Matrix für iontophorese
AU1098688A (en) Electrolytic transdermal delivery of proteins
PL328003A1 (en) Modulation of cytokin th 1/th 2 expression by means of ribavirin and ribavirin analoques in t lymphocytes
GR3022586T3 (en) Iontophoresis device using a rate-controlling membrane
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
ZA882335B (en) Redoc amino acids and reptides containing them
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
CS408391A3 (en) Novel peptides active on central neural system and cholinergic system
DE69010518D1 (de) Wässerige Desmopressin-CMC enthaltende Arzneizubereitung.
NZ235297A (en) Aqueous solution containing a protein and anionic polymer or salt and method of increasing the protein concentration of an aqueous solution
EP0723016A3 (en) Leukocyte activation factor
Garvin Student experiment with filter paper electrophoresis
JPS52148487A (en) Filter membrane of hollow fiber
ES8401631A1 (es) Un dispositivo para emplearlo en la determinacion de nivelesde gas en la sange.
SU1600502A1 (ru) Способ приготовления эритроцитарного диагностикума для индикации лекарственной аллергии к антибиотикам
ATE44751T1 (de) Zusammensetzungen zum behandeln von ischaemie im gehirn.